Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2025-12-24 @ 5:12 PM
NCT ID: NCT06232850
Eligibility Criteria: Inclusion Criteria: * Patient group: * Disability score (EDSS: Expanded Disability Status Scale) should be between 0-3. * Being between the ages of 18-50 * Not having had an attack in the last 3 months * Scoring 24 points or above on the Mini-Mental State Examination * Patients diagnosed with relapsing-remitting MS with a disease duration of at least 2 years * Patients without spasticity according to MAS Control group: * Volunteers in a similar age range who agreed to participate in the study * Being between the ages of 18-50 Exclusion Criteria: * Patient group: * Presence of diagnosed visual impairment * Having other chronic diseases not related to MS * Having any orthopedic, neurological, rheumatological or metabolic diagnosis that causes upper extremity involvement * History of hand and upper extremity disorders, peripheral nerve disorders, and medical or psychiatric disorders that may significantly affect cognitive function * Presence of wrist joint range of motion limitation Control group: * Having any orthopedic, neurological, rheumatological or metabolic diagnosis that causes upper extremity involvement * History of hand and upper extremity disorders, peripheral nerve disorders, and medical or psychiatric disorders that may significantly affect cognitive function * Presence of wrist joint range of motion limitation
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 50 Years
Study: NCT06232850
Study Brief:
Protocol Section: NCT06232850